These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 10778491

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Restoring the DHA levels in the brains of Zellweger patients.
    Martinez M.
    J Mol Neurosci; 2001; 16(2-3):309-16; discussion 317-21. PubMed ID: 11478386
    [Abstract] [Full Text] [Related]

  • 6. Docosahexaenoic acid therapy in docosahexaenoic acid-deficient patients with disorders of peroxisomal biogenesis.
    Martinez M.
    Lipids; 1996 Mar; 31 Suppl():S145-52. PubMed ID: 8729110
    [Abstract] [Full Text] [Related]

  • 7. Zellweger syndrome knockout mouse models challenge putative peroxisomal beta-oxidation involvement in docosahexaenoic acid (22:6n-3) biosynthesis.
    Infante JP, Huszagh VA.
    Mol Genet Metab; 2001 Jan; 72(1):1-7. PubMed ID: 11161822
    [Abstract] [Full Text] [Related]

  • 8. Effect of dietary Lorenzo's oil and docosahexaenoic acid treatment for Zellweger syndrome.
    Arai Y, Kitamura Y, Hayashi M, Oshida K, Shimizu T, Yamashiro Y.
    Congenit Anom (Kyoto); 2008 Dec; 48(4):180-2. PubMed ID: 18983586
    [Abstract] [Full Text] [Related]

  • 9. Polyunsaturated fatty acids in the developing human brain, erythrocytes and plasma in peroxisomal disease: therapeutic implications.
    Martinez M.
    J Inherit Metab Dis; 1995 Dec; 18 Suppl 1():61-75. PubMed ID: 9053556
    [Abstract] [Full Text] [Related]

  • 10. Dietary sesamin and docosahexaenoic and eicosapentaenoic acids synergistically increase the gene expression of enzymes involved in hepatic peroxisomal fatty acid oxidation in rats.
    Arachchige PG, Takahashi Y, Ide T.
    Metabolism; 2006 Mar; 55(3):381-90. PubMed ID: 16483883
    [Abstract] [Full Text] [Related]

  • 11. Docosahexaenoic acid--a new therapeutic approach to peroxisomal-disorder patients: experience with two cases.
    Martinez M, Pineda M, Vidal R, Conill J, Martin B.
    Neurology; 1993 Jul; 43(7):1389-97. PubMed ID: 8327143
    [Abstract] [Full Text] [Related]

  • 12. Docosahexaenoic acid therapy in peroxisomal diseases: results of a double-blind, randomized trial.
    Paker AM, Sunness JS, Brereton NH, Speedie LJ, Albanna L, Dharmaraj S, Moser AB, Jones RO, Raymond GV.
    Neurology; 2010 Aug 31; 75(9):826-30. PubMed ID: 20805528
    [Abstract] [Full Text] [Related]

  • 13. Early dietary treatments with Lorenzo's oil and docosahexaenoic acid for neurological development in a case with Zellweger syndrome.
    Tanaka K, Shimizu T, Ohtsuka Y, Yamashiro Y, Oshida K.
    Brain Dev; 2007 Oct 31; 29(9):586-9. PubMed ID: 17418516
    [Abstract] [Full Text] [Related]

  • 14. Clinical approach to inherited peroxisomal disorders: a series of 27 patients.
    Baumgartner MR, Poll-The BT, Verhoeven NM, Jakobs C, Espeel M, Roels F, Rabier D, Levade T, Rolland MO, Martinez M, Wanders RJ, Saudubray JM.
    Ann Neurol; 1998 Nov 31; 44(5):720-30. PubMed ID: 9818927
    [Abstract] [Full Text] [Related]

  • 15. Zellweger syndrome: diagnostic assays, syndrome delineation, and potential therapy.
    Wilson GN, Holmes RG, Custer J, Lipkowitz JL, Stover J, Datta N, Hajra A.
    Am J Med Genet; 1986 May 31; 24(1):69-82. PubMed ID: 3706414
    [Abstract] [Full Text] [Related]

  • 16. Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids.
    Rupp H, Wagner D, Rupp T, Schulte LM, Maisch B.
    Herz; 2004 Nov 31; 29(7):673-85. PubMed ID: 15580322
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of docosahexaenoic acid deficiency as a preventable risk factor for recurrent affective disorders: current status, future directions, and dietary recommendations.
    McNamara RK.
    Prostaglandins Leukot Essent Fatty Acids; 2009 Nov 31; 81(2-3):223-31. PubMed ID: 19515544
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Microdetermination of fatty acids by gas chromatography and cardiovascular risk stratification by the "EPA+DHA level".
    Rupp H, Rupp TP, Wagner D, Alter P, Maisch B.
    Herz; 2006 Dec 31; 31 Suppl 3():30-49. PubMed ID: 17575804
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.